Year-End Report — ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES (2007)

Firm

ASSOCIATION FOR ACCESSIBLE MEDICINES

Client

ASSOCIATION FOR ACCESSIBLE MEDICINES

Income

—

Expenses

$398,128

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Peru Free Trade Agreement - H.R.3688 Korea Free Trade Agreement Panama Free Trade Agreement Colombia Free Trade Agreement

Lobbyist	Covered position, as disclosed
GARY HEIMBERG	N/A
KATHLEEN D JAEGER	N/A
BRUCE LOTT	N/A
JASON R MONEY	N/A
REILLY O'CONNOR	N/A

Contacted: SENATE; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3688 (110th)

Copyright/Patent/Trademark CPT

Patent Reform - S.1195 and H.R.1908 Patent Settlements - S.316, H.R.1432, and H.R.1902

Lobbyist	Covered position, as disclosed
GARY HEIMBERG	N/A
KATHLEEN D JAEGER	N/A
BRUCE LOTT	N/A
JASON R MONEY	N/A
REILLY O'CONNOR	N/A

Contacted: Food & Drug Administration (FDA); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1908 (110th), H.R. 1902 (110th), H.R. 1432 (110th), S. 1195 (110th), S. 316 (110th)

Medicare/Medicaid MMM

Medicaid Reimbursement - S.1951, H.R.3140, and H.R.3700 S-Chip/Rebates - S.1893 and H.R.3162

Lobbyist	Covered position, as disclosed
GARY HEIMBERG	N/A
KATHLEEN D JAEGER	N/A
BRUCE LOTT	N/A
JASON R MONEY	N/A
REILLY O'CONNOR	N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Food & Drug Administration (FDA)

Bills named: H.R. 3140 (110th), H.R. 3162 (110th), H.R. 3700 (110th), S. 1893 (110th), S. 1951 (110th)

Generic Biologics - S.623, S.1695, H.R.1038, and H.R.1956 Pediatric Exclusivity - S.1082, H.R.2900, and H.R.3580 Drug Safety - S.484, S.1082, H.R.3580 Authorized Generics - S.438 and H.R.806 Citizen Petitions - S.1088, S.25, and H.R.3580 Import Safety - H.R.3610 Counterfeit Drugs - S.242, S.1082, H.R.780, H.R.2710, H.R.3580, and H.R.3610

Lobbyist	Covered position, as disclosed
GARY HEIMBERG	N/A
KATHLEEN D JAEGER	N/A
BRUCE LOTT	N/A
JASON R MONEY	N/A
REILLY O'CONNOR	N/A

Contacted: U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 806 (110th), H.R. 2710 (110th), H.R. 3580 (110th), H.R. 1038 (110th), S. 1695 (110th), S. 1082 (110th), H.R. 2900 (110th), S. 484 (110th), S. 1088 (110th), H.R. 780 (110th), S. 242 (110th), H.R. 1956 (110th), S. 25 (110th), S. 623 (110th), S. 438 (110th), H.R. 3610 (110th)

Budget/Appropriations BUD

Office of Generic Drugs - S.1859, H.R.2764, H.R.3161, and

Lobbyist	Covered position, as disclosed
GARY HEIMBERG	N/A
KATHLEEN D JAEGER	N/A
BRUCE LOTT	N/A
JASON R MONEY	N/A
REILLY O'CONNOR	N/A

Contacted: U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 2764 (110th), H.R. 3161 (110th), S. 1859 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.